| Identification | Back Directory | [Name]
Motesanib | [CAS]
453562-69-1 | [Synonyms]
D06678
CS-1108
motesanib
Motesanib Base
AMG 706; AMG-706
AMG-706(Motesanib)
Motesanib (AMG-706) Base)
N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethylamino)nicotinamide
N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethylamino)nicotinamide,AMG706
N-(3,3-diMethylindolin-6-yl){2-[(4-pyridylMethyl)-aMino](3-pyridyl)}-carboxaMide
N-(2,3-Dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide
3-PyridinecarboxaMide, N-(2,3-dihydro-3,3-diMethyl-1H-indol-6-yl)-2-[(4-pyridinylMethyl)aMino]- | [Molecular Formula]
C22H23N5O | [MDL Number]
MFCD10567689 | [MOL File]
453562-69-1.mol | [Molecular Weight]
373.45 |
| Chemical Properties | Back Directory | [Melting point ]
147-150°C | [Boiling point ]
517.3±50.0 °C(Predicted) | [density ]
1.251 | [storage temp. ]
Refrigerator | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
White powder solid. | [pka]
11.75±0.40(Predicted) | [color ]
Pale Yellow |
| Hazard Information | Back Directory | [Chemical Properties]
Pale Yellow Solid | [Uses]
Motesanib Diphosphate (AMG-706) is a potent ATP-competitive inhibitor of VEGFR1/2/3, PDGFR, c-Kit and Ret with IC50 of 2 nM/3 nM/6 nM, 84 nM, 8 nM and 59 nM, respectively. | [Uses]
Motesanib is an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma. | [Definition]
ChEBI:Motesanib is a pyridinecarboxamide. | [Biological Activity]
Motesanib potently inhibits angiogenesis and induces regression in tumor xenografts. | [target]
VEGFR1 | [storage]
Store at -20°C |
|
|